All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Listed as ongoing, but also has a completion date and reported results | 2013-002248-98 | Anti-CD3 MAB (Teplizumab) for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus ANTI-CD3 MAB (TEPLIZUMAB) per la prevenzione del diabete in PARENTI a rischio di sviluppare di... | 2019-12-16 | bad-data |
Other | 2013-005535-24 | Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis (Wegener’s) (ABROGATE) | not-yet-due | |
Ongoing | 2016-001923-30 | Exploring Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus Studio sugli effetti dell'insulina orale sul sistema immunitario nei famigliari a rischio di diabete melli... | not-yet-due |